SAMSUNG PHARM. Co., LTD. Market Cap

SAMSUNG PHARM. Co., LTD. has a market cap or net worth of 141.75 billion as of April 17, 2025. Its market cap has decreased by -17.52% in one year.

Market Cap

141.75B

Enterprise Value

n/a

Revenue

44.29B

Ranking

n/a

PE Ratio

11.15

Stock Price

1,508.00

Market Cap Chart

Since August 31, 1995, SAMSUNG PHARM. Co., LTD.'s market cap has increased from 17.88B to 141.75B, an increase of 692.55%. That is a compound annual growth rate of 7.23%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2025	141.75B	-2.08%
Dec 30, 2024	144.76B	-0.84%
Dec 28, 2023	145.99B	-18.99%
Dec 29, 2022	180.22B	-45.48%
Dec 30, 2021	330.57B	-11.17%
Dec 30, 2020	372.12B	50.47%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	75.37T
Celltrion	34.28T
ALTEOGEN	20.04T
Yuhan	8,580.84B
SK Biopharmaceuticals	8,144.58B
HLB Co., Ltd.	7,356.32B
LigaChem Biosciences	3,856.78B
Peptron	3,778.83B

Market Cap Rankings